文献速递慢阻肺

香烟烟雾诱导实验性慢性阻塞性肺疾病的时间分辨蛋白质组学分析

Time-resolved proteomic profiling of cigarette smoke-induced experimental chronic obstructive pulmonary disease.
PubMed 文献 · Respirology · 2021-07-05

该研究采用定量标记蛋白质组学技术,对香烟烟雾诱导8周并进展至12周的小鼠实验性COPD肺组织蛋白质组变化进行追踪,量化7324种蛋白质。诱导期蛋白表达改变较少,8周时出现269种蛋白表达改变,与人类COPD标志性病理特征出现时间吻合,12周疾病进展时降至27种。差异表达蛋白经其他小鼠和人类COPD支气管活检样本验证,涉及RNA生物合成和炎症反应调节因子及线粒体功能障碍。

要点

  • 8周时269种蛋白表达改变,与人类COPD标志性病理特征出现同步。
  • 12周疾病进展时仅27种蛋白改变,提示分子变化在诱导期更为显著。
  • HNRNPC、MSI2和S100A1等蛋白参与COPD发病和进展。

核心结论

  • 研究提供了COPD发病和疾病进展相关的详细肺组织蛋白质组图谱,为开发有效的新治疗策略建立平台。

研究设计与样本

  • 采用定量标记蛋白质组学方法,对香烟烟雾诱导8周并进展至12周的小鼠实验性COPD肺组织蛋白质组进行时间分辨分析。
  • 量化7324种蛋白质,并与年龄匹配对照比较。
  • 差异表达蛋白经其他小鼠和人类COPD支气管活检样本验证。

主要发现

  • 诱导期4周和6周时分别有18种和16种蛋白表达改变(与年龄匹配对照相比)。
  • 8周时269种蛋白表达改变,此时出现人类COPD标志性病理特征。
  • 12周疾病进展时蛋白改变降至27种。
  • RNA生物合成相关蛋白(HNRNPC和MSI2)和炎症反应调节因子(S100A1)变化显著,并发生线粒体功能障碍和氧化应激蛋白改变。

局限性

  • 研究基于香烟烟雾诱导的小鼠实验性COPD模型,结论外推至人类需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is the third leading cause of illness and death worldwide. Current treatments aim to control symptoms with none able to reverse disease or stop its progression. We explored the major molecular changes in COPD pathogenesis. METHODS: We employed quantitative label-based proteomics to map the changes in the lung tissue proteome of cigarette smoke-induced experimental COPD that is induced over 8 weeks and progresses over 12 weeks. RESULTS: Quantification of 7324 proteins enabled the tracking of changes to the proteome. Alterations in protein expression profiles occurred in the induction phase, with 18 and 16 protein changes at 4- and 6-week time points, compared to age-matched controls, respectively. Strikingly, 269 proteins had altered expression after 8 weeks when the hallmark pathological features of human COPD emerge, but this dropped to 27 changes at 12 weeks with disease progression. Differentially expressed proteins were validated using other mouse and human COPD bronchial biopsy samples. Major changes in RNA biosynthesis (heterogeneous nuclear ribonucleoproteins C1/C2 [HNRNPC] and RNA-binding protein Musashi homologue 2 [MSI2]) and modulators of inflammatory responses (S100A1) were notable. Mitochondrial dysfunction and changes in oxidative stress proteins also occurred. CONCLUSION: We provide a detailed proteomic profile, identifying proteins associated with the pathogenesis and disease progression of COPD establishing a platform to develop effective new treatment strategies.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Skerrett-Byrne DA, Bromfield EG, Murray HC, et al. Time-resolved proteomic profiling of cigarette smoke-induced experimental chronic obstructive pulmonary disease. Respirology. 2021. PMID: 34224176. doi:10.1111/resp.14111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。